Prognostic role of intraparotid lymph node metastasis in primary parotid cancer: Systematic review
Files
Publication date
2021-03
Authors
Guntinas-Lichius, Orlando
Thielker, Jovanna
Robbins, K Thomas
Olsen, Kerry D
Shaha, Ashok R
Mäkitie, Antti A
de Bree, Remco
Vander Poorten, Vincent
Quer, Miquel
Rinaldo, Alessandra
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
Abstract
BACKGROUND: The prognostic importance of intraparotid lymph node metastasis (P+) in patients with primary parotid gland carcinoma is unclear. METHODS: Nineteen retrospective and noncomparative cohort studies, published between 1992 and 2020, met the inclusion criteria and included 2202 patients for this systematic review. RESULTS: The pooled prevalence of the P in adult patients in the unselected studies was 24.10% (95% confidence interval = 17.95-30.25). The number of P+ lymph nodes per patient was counted in only three studies and ranged from 1 to 11. The 5-year recurrence-free survival rate based on Kaplan-Meier analysis varied from 83% to 88% in P- patients compared to 36% to 54% in P+ patients. The average hazard ratio for tumor recurrence in patients with P+ compared to P- was 2.67 ± 0.58. CONCLUSIONS: P+ is an independent negative prognostic factor in primary parotid gland cancer and should be included into the treatment planning.
Keywords
clinical significance, intraparotid lymph node metastasis, nodal metastasis, prevalence, primary parotid cancer, survival, Otorhinolaryngology, Review, Journal Article
Citation
Guntinas-Lichius, O, Thielker, J, Robbins, K T, Olsen, K D, Shaha, A R, Mäkitie, A A, de Bree, R, Vander Poorten, V, Quer, M, Rinaldo, A, Kowalski, L P, Rodrigo, J P, Hamoir, M & Ferlito, A 2021, 'Prognostic role of intraparotid lymph node metastasis in primary parotid cancer : Systematic review', Head & neck, vol. 43, no. 3, pp. 997-1008. https://doi.org/10.1002/hed.26541